Polo Vicente, Larrosa José M, Ferreras Antonio, Borque Enrique, Pablo Luis E, Honrubia Francisco M
Department of Ophthalmology, Isabel la Católica 1-3, 50.009 Zaragoza, Spain.
Ann Ophthalmol (Skokie). 2008 Fall-Winter;40(3-4):157-62.
We evaluated the efficacy of fixed combination of 0.005% latanoprost and 0.5% timolol maleate administered once daily in the evening for treating glaucoma patients. This combination proved an effective alternative to achieve an additional intraocular pressure IOP lowering effect in patients treated with either drug alone and as an alterative in patients treated with unfixed combination of latanoprost and timolol and optimal IOP control.
我们评估了每晚一次给予0.005%拉坦前列素和0.5%马来酸噻吗洛尔固定复方制剂治疗青光眼患者的疗效。对于单独使用这两种药物治疗的患者,该复方制剂被证明是一种有效的替代方案,可实现额外的降低眼压(IOP)效果,并且对于使用拉坦前列素和噻吗洛尔非固定复方制剂治疗且眼压控制不理想的患者而言,也是一种替代选择。